Search

Athletes, rest easy: Extreme exercise does not raise heart disease risk or mortality

Responsibilities Jump to … Children in the Workplace Communicating with the Media Conflict of Interest Descriptions of Student Groups Handbook of Operating Procedures Postdoctoral Training Program Responsibility to Trainees Mentoring Graduate Students Your Own Authorship Policy Children in the Workpl…

UT Southwestern researchers equipped physicians with web-based software that guided them through protocols for screening patients, prescribing treatments, and measuring their progress.

A new molecular mechanism discovered by UT Southwestern researchers indicates that drugs currently used to treat less than 10 percent of breast cancer patients could have broader effectiveness in treating all cancers where the drugs are used, including ovarian and prostate cancers. The new study, published in Molecular Cell, also revealed a potential biomarker indicating when these drugs, called PARP inhibitors, can be unleashed in the fight against cancer.

The hormone LEAP2, which naturally blocks the “hunger” hormone ghrelin, is elevated in people with obesity, especially after eating – raising hopes for a treatment that could one day more effectively reduce appetite and, hence, obesity.

UT Southwestern’s Dr. Donald Seldin Plaza are now greeted by two stunning new sculptures that have effectively changed the face of South Campus. The pieces – Dumna by Ursula von Rydingsvard and an untitled work by Joel Shapiro – were recently gifted to UT Southwestern by an anonymous donor.

UT Southwestern serves a very diverse population throughout North Texas, and the institution aims to attract a campus community that reflects that diversity

Find open career opportunities in the Division of General Internal medicine at UT Southwestern Medical Center.

Lauren Duan spent the summer working alongside UT Southwestern faculty members and postdocs focused on cardiac regeneration and investigating how cardiomyocytes can be programmed to regenerate and resist cell death.

Dr. John Schoggins, known for his studies on antiviral immunity, has been named a 2019 Investigator in the Pathogenesis of Infectious Disease. He is among 11 early career scientists selected for the Burroughs Wellcome Fund (BWF) award, which provides research funding of $500,000 over five years.